SZi001+Abstract+text+only.pdf (16.92 kB)

Facilitating the operational readiness of the NHS for the in-house manufacture and delivery of autologous cell therapy [210]

Download (16.92 kB)
journal contribution
posted on 16.08.2017, 09:01 by S. Ziya, Nick Medcalf, Alicia J. El Haj, K.T. Wright
Facilitating the operational readiness of the NHS for the in-house manufacture and delivery of autologous cell therapy [210]

History

School

  • Mechanical, Electrical and Manufacturing Engineering

Published in

CYTOTHERAPY

Volume

19

Issue

5

Pages

S89 - S89

Citation

ZIYA, S. ... et al, 2017. Facilitating the operational readiness of the NHS for the in-house manufacture and delivery of autologous cell therapy [210]. Cytotherapy, 19 (5), Supplement, p.S89.

Publisher

© Elsevier

Version

AM (Accepted Manuscript)

Publisher statement

This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/

Publication date

2017

Notes

This paper was published in the journal Cytotherapy and the definitive published version is available at https://doi.org/10.1016/j.jcyt.2017.02.219. This is the abstract for a poster presented at the ISCT 2017 Annual Meeting.

ISSN

1465-3249

eISSN

1477-2566

Language

en

Alternative title

210 - Facilitating the operational readiness of the NHS for the in-house manufacture and delivery of autologous cell therapy

Exports

Logo branding

Keywords

Exports